WO2004056380A3 - Composition comprenant un extrait d'une plante et un sucre et pouvant etre utilisee pour inhiber une proliferation bacterienne - Google Patents

Composition comprenant un extrait d'une plante et un sucre et pouvant etre utilisee pour inhiber une proliferation bacterienne Download PDF

Info

Publication number
WO2004056380A3
WO2004056380A3 PCT/GB2003/005578 GB0305578W WO2004056380A3 WO 2004056380 A3 WO2004056380 A3 WO 2004056380A3 GB 0305578 W GB0305578 W GB 0305578W WO 2004056380 A3 WO2004056380 A3 WO 2004056380A3
Authority
WO
WIPO (PCT)
Prior art keywords
sugar
composition
plant extract
inhibiting bacterial
bacterial proliferation
Prior art date
Application number
PCT/GB2003/005578
Other languages
English (en)
Other versions
WO2004056380A2 (fr
Inventor
Paul Clayton
Helen Conn
Original Assignee
Forum Bioscience Holdings Ltd
Paul Clayton
Helen Conn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forum Bioscience Holdings Ltd, Paul Clayton, Helen Conn filed Critical Forum Bioscience Holdings Ltd
Priority to AU2003292447A priority Critical patent/AU2003292447A1/en
Publication of WO2004056380A2 publication Critical patent/WO2004056380A2/fr
Publication of WO2004056380A3 publication Critical patent/WO2004056380A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

L'invention concerne une composition comprenant un extrait d'une plante membre de la famille des Ericaceae, Rosaceae, Pinaceae ou Vitaceae et au moins un sucre qui n'est pas métabolisé ou ne l'est que partiellement par le corps humain ou animal.
PCT/GB2003/005578 2002-12-23 2003-12-19 Composition comprenant un extrait d'une plante et un sucre et pouvant etre utilisee pour inhiber une proliferation bacterienne WO2004056380A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003292447A AU2003292447A1 (en) 2002-12-23 2003-12-19 Composition comprising plant extract and a sugar for use in inhibiting bacterial proliferation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0230042.4A GB0230042D0 (en) 2002-12-23 2002-12-23 Composition comprising plant extract and a sugar for use in inhibiting bacterial proliferation
GB0230042.4 2002-12-23

Publications (2)

Publication Number Publication Date
WO2004056380A2 WO2004056380A2 (fr) 2004-07-08
WO2004056380A3 true WO2004056380A3 (fr) 2004-09-16

Family

ID=9950342

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2003/005578 WO2004056380A2 (fr) 2002-12-23 2003-12-19 Composition comprenant un extrait d'une plante et un sucre et pouvant etre utilisee pour inhiber une proliferation bacterienne

Country Status (3)

Country Link
AU (1) AU2003292447A1 (fr)
GB (2) GB0230042D0 (fr)
WO (1) WO2004056380A2 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0316550D0 (en) * 2003-07-15 2003-08-20 Forum Bioscience Holdings Ltd Sucrose substitute
GB0426068D0 (en) * 2004-11-29 2004-12-29 Passion For Life Healthcare Lt Composition with bacteria blocking action
EP1882473A1 (fr) * 2006-07-28 2008-01-30 Indena S.P.A. Utilistation d'anthocyanosides pour la préparation de formulations pour le traitement de la mucosite induite par les médicaments antitumoraux
WO2008157205A2 (fr) * 2007-06-15 2008-12-24 Duke University Procédés et compositions pour le traitement des infections de l'appareil urinaire en utilisant des agents qui imitent ou augmentent l'amp cyclique
US20110064706A1 (en) * 2008-01-11 2011-03-17 U.S. Nutraceuticals, Llc D/B/A Valensa International Method of preventing, controlling and ameliorating urinary tract infections and supporting digestive health by using a synergistic cranberry derivative, a d-mannose composition and a proprietary probiotic blend
US20090180999A1 (en) * 2008-01-11 2009-07-16 U.S. Nutraceuticals, Llc D/B/A Valensa International Method of preventing, controlling and ameliorating urinary tract infections using cranberry derivative and d-mannose composition
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITMI20130793A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
EP2929873A1 (fr) * 2014-04-07 2015-10-14 Intermed S.A. Compositions de nettoyage de la peau
US10300099B2 (en) * 2014-08-19 2019-05-28 Kolinpharma S.P.A. Composition for the treatment and prevention of urinary tract infections
IT201600130012A1 (it) * 2016-12-22 2018-06-22 Neilos S R L Composizione per uso nel trattamento di disturbi dell'apparato uro-genitale
CN107669691A (zh) * 2017-11-24 2018-02-09 天津医科大学 单糖木糖制品在制备预防和治疗泌尿系统感染药物中的应用

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4038421A (en) * 1975-05-16 1977-07-26 Roussel-Uclaf Nonalcoholic beverage
DE3427014A1 (de) * 1984-07-21 1986-01-23 Moser, Hanspeter H., Dr.med., 3012 Langenhagen Praeparat zur prophylaxe und therapie unkomplizierter harnwegsinfekte
JPH04334320A (ja) * 1991-05-10 1992-11-20 Nakano Vinegar Co Ltd 整腸効果作用組成物
WO1997029763A1 (fr) * 1996-02-14 1997-08-21 The Procter & Gamble Company Compositions pour le traitement de troubles urogenitaux et intestinaux contenant une substance derivee d'especes de plantes de la famille des ericaceae et un facteur de croissance de bacteries d'acide lactique
WO1999007239A1 (fr) * 1997-07-25 1999-02-18 Oy Borago Ab Preparation d'aliment fonctionnel
US6210681B1 (en) * 1999-09-07 2001-04-03 Jlb, Inc. Plant proanthocyanidin extracts

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL134904A0 (en) * 1997-09-09 2001-05-20 Univ Rutgers Plant proanthocyanidin extract effective at inhibiting adherence of bacteria with p-type fimbriae to surfaces
WO2003084559A1 (fr) * 2002-04-03 2003-10-16 Arctos Pharmaceuticals, Incorporated Compositions de l'espece vaccinium comportant de nouvelles proprietes benefiques

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4038421A (en) * 1975-05-16 1977-07-26 Roussel-Uclaf Nonalcoholic beverage
DE3427014A1 (de) * 1984-07-21 1986-01-23 Moser, Hanspeter H., Dr.med., 3012 Langenhagen Praeparat zur prophylaxe und therapie unkomplizierter harnwegsinfekte
JPH04334320A (ja) * 1991-05-10 1992-11-20 Nakano Vinegar Co Ltd 整腸効果作用組成物
WO1997029763A1 (fr) * 1996-02-14 1997-08-21 The Procter & Gamble Company Compositions pour le traitement de troubles urogenitaux et intestinaux contenant une substance derivee d'especes de plantes de la famille des ericaceae et un facteur de croissance de bacteries d'acide lactique
WO1999007239A1 (fr) * 1997-07-25 1999-02-18 Oy Borago Ab Preparation d'aliment fonctionnel
US6210681B1 (en) * 1999-09-07 2001-04-03 Jlb, Inc. Plant proanthocyanidin extracts

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 199301, Derwent World Patents Index; Class B03, AN 1993-005498, XP002278031 *
DAVIS J A ET AL: "Studies of mannose metabolism and effects of long-term mannose ingestion in the mouse", BBA - GENERAL SUBJECTS, ELSEVIER SCIENCE PUBLISHERS, NL, vol. 1528, no. 2-3, 3 October 2001 (2001-10-03), pages 116 - 126, XP004312008, ISSN: 0304-4165 *
EVANS A T; FOX C; HELMICK J R: "The Ability of Mannose, Fructose, Maltose and Galactose to agglutinate Escherichia Coli as a defense against urinary tract infection", ABSTRACTS OF THE ANNUAL MEETING OF THE AMERICAN SOCIETY FOR MICROBIOLOGY, vol. 80, 1980, pages Abstract1119, XP009029953 *
FOO L Y ET AL: "The structure of cranberry proanthocyanidins which inhibit adherence of uropathogenic P-fimbriated Escherichia coli in vitro", PHYTOCHEMISTRY, PERGAMON PRESS, GB, vol. 54, no. 2, 1 May 2000 (2000-05-01), pages 173 - 181, XP004291466, ISSN: 0031-9422 *
SOBOTA A E: "INHIBITION OF BACTERIAL ADHERENCE BY CRANBERRY JUICE: POTENTIAL USE FOR THE TREATMENT OF URINARY TRACT INFECTIONS", JOURNAL OF UROLOGY, BALTIMORE, MD, US, vol. 131, no. 5, 1 May 1984 (1984-05-01), pages 1013 - 1016, XP002074760, ISSN: 0022-5347 *

Also Published As

Publication number Publication date
AU2003292447A1 (en) 2004-07-14
GB0329467D0 (en) 2004-01-28
GB2396811A (en) 2004-07-07
GB0230042D0 (en) 2003-01-29
WO2004056380A2 (fr) 2004-07-08

Similar Documents

Publication Publication Date Title
WO2004056380A3 (fr) Composition comprenant un extrait d'une plante et un sucre et pouvant etre utilisee pour inhiber une proliferation bacterienne
WO2005041924A3 (fr) Administration de levodopa et de carbidopa
TW200616545A (en) Fungicidal compositions
WO2005115473A3 (fr) Aliment nutritionnel, composition, traitement et procede d'utilisation
WO2006013441A3 (fr) Utilisation de bacteries probiotiques dans la preparation de compositions topiques destinees a la protection de la peau
WO2007022344A3 (fr) Procedes et compositions permettant de prevenir et de traiter les maladies renales
HK1067073A1 (en) Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
WO2006096439A3 (fr) Compositions pharmaceutiques destinees au traitement et/ou a la prevention de la schizophrenie et de maladies associees
WO2005034650A8 (fr) Complement nutritionnel d'amaigrissement
EP1277473A4 (fr) Remedes
WO2002007533A3 (fr) Composition nutritionnelle
WO2007104867A3 (fr) Compositions cosmetiques, pharmaceutiques, alimentaires et veterinaires dont l'action d'activation des genes de type sirtuin permet de retarder le vieillissement des mammiferes et ses effets nefastes
EP1588627A4 (fr) Procede de reduction d'un gout desagreable et/ou d'une odeur desagreable
WO2006002976A3 (fr) Formulation dietetique contre l'arthrose de chien
WO2006012213A3 (fr) Composition et procede d'administration de produits phytochimiques
EP1649864A4 (fr) Composition therapeutique et/ou preventive pour parodontopathies
MX2007004879A (es) Proteccion de ingredientes de alimentos bioactivos por medio de encapsulacion.
WO2007059953A8 (fr) Préparation contenant une composition polyphénolique et de l'isomaltulose
WO2007113291A3 (fr) Compositions alimentaires favorisant la croissance osseuse et le maintien de la santé osseuse et méthodes associées
WO2007075255A3 (fr) Composition de gomme mastic utilisable en tant que complement alimentaire pour les humains et les animaux
WO2008128766A3 (fr) Composition de boisson
WO2003007732A3 (fr) Composition d'aliment pour animaux permettant de reguler le poids vif et de prevenir l'obesite ainsi que des troubles associes chez les animaux
EP1869985A4 (fr) Composition de fer contenant des proteines de lait
WO2002045733A3 (fr) Preparations orales ayant une action de soulagement des demageaisons ou un effet antiprurigineux
WO2002045733A1 (fr) Preparations orales ayant une action de soulagement des demageaisons ou un effet antiprurigineux

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP